Media Hits

A CRISPR-based screening platform helped Charles Gersbach and colleagues identify a transcription factor that makes CAR T cells better at killing cancer cells.

Two new strategies using deep brain stimulation can improve symptoms of Parkinson’s disease, Duke University researchers have found

Weekly science news radio show features research from Junjie Yao on developing ink that can be used to 3D print structures within the body using sound

BME Professor Junjie Yao has helped develop a 3D bioprinting technique that uses sound waves and injectable ink to create structures deep within human tissue

BME Professor Charles Gersbach has discovered a single master regulator of the genome that can be used to reprogram a network of thousands of genes in T cells to better treat cancer

BME Professor Jonathan Viventi’s speech prosthetic might one day help people unable to talk due to neurological disorders regain the ability to communicate through a brain-computer interface.

BME Professor Junjie Yao speaks to the fragility of most frogs species due to their biology.

BME Professor Daniel Reker's research using "active learning" to identify weaknesses in a machine learning dataset such as too many of one type of input is included in a weekly roundup on advances in AI.

BME Professor Roarke Horstmeyer comments on the potential biomedical applications of a new method for creating large-scale single-photon detectors.

BME Professor Cameron McIntyre and colleagues have spent the past seven years developing HoloSNS, a visualization tool that translates human brain scans into interactive holograms.

BME Professor Marc Sommer added his name to an open letter saying guarding against human extinction from AI should be a global priority like pandemics or nuclear war. “It sounds like science fiction, but it is something to be concerned about.”

Tune Therapeutics, a company spun out of the laboratory of BME Professor Charles Gersbach, has demonstrated that its CRISPR-based technology can modulate gene regulation in monkeys to cut LDL, or "bad" cholesterol, by more than 50%.